Innovation4 ways Amazon is moving into healthcare
FinanceAzar: Drug Importation May Not Be a Gimmick After All
There may be 'safe, select avenues for importation' that the U.S. government should consider, the HHS secretary said.
FinanceFDA Biosimilar Action Plan Aims for Affordability Through Competition
Commissioner Scott Gottlieb advocated for the plan during a Brookings Institution presentation.
InnovationFDA Looks to Ease Restrictions on Some Prescription Drugs
Commissioner Scott Gottlieb says the proposal would improve competition, expand access, empower consumers, and provide more affordable options.
FinanceRural Providers Show Support for 340B in Drug Pricing Blueprint
On the final day for public comment on the Trump administration's blueprint to lower prescription drug prices, rural providers and...
FinancePhysician Fee Schedule: CMS to Trim Part B Add-On for New Drugs
The proposed change for 2019 would reduce the wholesale acquisition cost add-on from 6% to 3%, decreasing the amount of...